用抑制氧化应激和亚硝化应激的泰诺联合用药可以预防I型糖尿病和早期失明吗?

ISRN Toxicology Pub Date : 2011-10-05 Print Date: 2011-01-01 DOI:10.5402/2011/461928
Knox Van Dyke, Erica Ghareeb, Robert Hoeldtke, Mark Van Dyke, Chris Van Dyke, David Van Thiel
{"title":"用抑制氧化应激和亚硝化应激的泰诺联合用药可以预防I型糖尿病和早期失明吗?","authors":"Knox Van Dyke,&nbsp;Erica Ghareeb,&nbsp;Robert Hoeldtke,&nbsp;Mark Van Dyke,&nbsp;Chris Van Dyke,&nbsp;David Van Thiel","doi":"10.5402/2011/461928","DOIUrl":null,"url":null,"abstract":"<p><p>Since oxidative/nitrosative stress cause diabetes, can we prevent this chemistry generating the disease? Streptozotocin causes diabetes by entering the pancreatic beta cell generating excessive nitric oxide which reacts with oxygen creating a toxin possibly peroxynitrite, dinitrogen trioxide, dinitrogen tetraoxide and so forth. The toxic compounds damage the DNA causing beta cell death. This prevents insulin synthesis, storage and release. By using antioxidant substances that destroy the nitric-oxide-based toxins (e.g., carboxy-PTIO (oxidizes nitric oxide), polyphenolic-quercetin and monophenolic acetaminophen (Tylenol)) which are oxidation and nitration targets can the diabetes I causing toxins in animals be destroyed? Will this tri-drug combination completely prevent the deleterious effects of diabetes namely poor blood glucose control and blindness from cataracts for the entire length of the experiment (one year). These disease reversal experiments were accomplished in rats where the streptozotocin-diabetic effects were completely thwarted. In vitro experiments were accomplished to provide the scientific basis for the experimental results in animals.</p>","PeriodicalId":14674,"journal":{"name":"ISRN Toxicology","volume":"2011 ","pages":"461928"},"PeriodicalIF":0.0000,"publicationDate":"2011-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658840/pdf/","citationCount":"5","resultStr":"{\"title\":\"Can diabetes I and early blindness be prevented using a tylenol combination which inhibits oxidative and nitrosative stress?\",\"authors\":\"Knox Van Dyke,&nbsp;Erica Ghareeb,&nbsp;Robert Hoeldtke,&nbsp;Mark Van Dyke,&nbsp;Chris Van Dyke,&nbsp;David Van Thiel\",\"doi\":\"10.5402/2011/461928\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Since oxidative/nitrosative stress cause diabetes, can we prevent this chemistry generating the disease? Streptozotocin causes diabetes by entering the pancreatic beta cell generating excessive nitric oxide which reacts with oxygen creating a toxin possibly peroxynitrite, dinitrogen trioxide, dinitrogen tetraoxide and so forth. The toxic compounds damage the DNA causing beta cell death. This prevents insulin synthesis, storage and release. By using antioxidant substances that destroy the nitric-oxide-based toxins (e.g., carboxy-PTIO (oxidizes nitric oxide), polyphenolic-quercetin and monophenolic acetaminophen (Tylenol)) which are oxidation and nitration targets can the diabetes I causing toxins in animals be destroyed? Will this tri-drug combination completely prevent the deleterious effects of diabetes namely poor blood glucose control and blindness from cataracts for the entire length of the experiment (one year). These disease reversal experiments were accomplished in rats where the streptozotocin-diabetic effects were completely thwarted. In vitro experiments were accomplished to provide the scientific basis for the experimental results in animals.</p>\",\"PeriodicalId\":14674,\"journal\":{\"name\":\"ISRN Toxicology\",\"volume\":\"2011 \",\"pages\":\"461928\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-10-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658840/pdf/\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ISRN Toxicology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5402/2011/461928\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2011/1/1 0:00:00\",\"PubModel\":\"Print\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN Toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5402/2011/461928","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2011/1/1 0:00:00","PubModel":"Print","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

摘要

既然氧化/亚硝化应激会导致糖尿病,我们能阻止这种化学反应产生这种疾病吗?链脲佐菌素通过进入胰腺细胞产生过量的一氧化氮导致糖尿病,一氧化氮与氧气反应产生一种毒素,可能是过氧亚硝酸盐,三氧化二氮,四氧化二氮等等。有毒化合物会破坏DNA,导致细胞死亡。这阻碍了胰岛素的合成、储存和释放。通过使用抗氧化物质破坏一氧化氮毒素(如羧基ptio(氧化一氧化氮),多酚-槲皮素和单酚类对乙酰氨基酚(泰诺)),这些是氧化和硝化的目标,可以破坏动物体内引起糖尿病的毒素吗?这种三联药组合能否在整个实验期间(一年)完全预防糖尿病的有害影响,即血糖控制不佳和白内障失明?这些疾病逆转实验是在大鼠中完成的,其中链脲佐菌素对糖尿病的影响完全被挫败。完成体外实验,为动物实验结果提供科学依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Can diabetes I and early blindness be prevented using a tylenol combination which inhibits oxidative and nitrosative stress?

Since oxidative/nitrosative stress cause diabetes, can we prevent this chemistry generating the disease? Streptozotocin causes diabetes by entering the pancreatic beta cell generating excessive nitric oxide which reacts with oxygen creating a toxin possibly peroxynitrite, dinitrogen trioxide, dinitrogen tetraoxide and so forth. The toxic compounds damage the DNA causing beta cell death. This prevents insulin synthesis, storage and release. By using antioxidant substances that destroy the nitric-oxide-based toxins (e.g., carboxy-PTIO (oxidizes nitric oxide), polyphenolic-quercetin and monophenolic acetaminophen (Tylenol)) which are oxidation and nitration targets can the diabetes I causing toxins in animals be destroyed? Will this tri-drug combination completely prevent the deleterious effects of diabetes namely poor blood glucose control and blindness from cataracts for the entire length of the experiment (one year). These disease reversal experiments were accomplished in rats where the streptozotocin-diabetic effects were completely thwarted. In vitro experiments were accomplished to provide the scientific basis for the experimental results in animals.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Cadmium Impairs p53 Activity in HepG2 Cells. Reduced life expectancy model for effects of long term exposure on lethal toxicity with fish. Paraben levels in an urban community of Western Canada. Cytotoxic effects of benzene metabolites on human sperm function: an in vitro study. Activation of the NF κ B Pathway Enhances AhR Expression in Intestinal Caco-2 Cells.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1